Effect of dipyridamole plus aspirin on hemodialysis graft patency - Wikidata - awgldk - TriplyDB

Effect of dipyridamole plus aspirin on hemodialysis graft patency

Effect of dipyridamole plus aspirin on hemodialysis graft patency

http://www.wikidata.org/entity/Q34607985

about

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts Antiplatelet agents for chronic kidney disease Antiplatelet agents for chronic kidney disease Hemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patients Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial Inhibition of platelet activation could decrease thrombotic events in hemodialysis PF4/H antibody-positive patients.The longevity of arteriovenous graft for hemodialysis patients--externally supported or nonsupported.Purinergic signaling during inflammation.Statin therapy is not associated with improved vascular access outcomes.Use of aspirin associates with longer primary patency of hemodialysis grafts.Vascular access choice in incident hemodialysis patients: a decision analysis."Venopathy" at work: recasting neointimal hyperplasia in a new light.Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis Severe venous neointimal hyperplasia prior to dialysis access surgery Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft.Association of factor V gene polymorphism with arteriovenous graft failure A biodegradable perivascular wrap for controlled, local and directed drug delivery.Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis.Medication adherence in randomized controlled trials evaluating cardiovascular or mortality outcomes in dialysis patients: A systematic review A Patient with Recurrent Arteriovenous Graft Thrombosis.Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients Clinical utility of far-infrared therapy for improvement of vascular access blood flow and pain control in hemodialysis patients.Thrombophilia and arteriovenous fistula survival in ESRD Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients.Vascular access today Temporal risk profile for infectious and noninfectious complications of hemodialysis access.From basic biology to randomized clinical trial: the Beta Radiation for Arteriovenous Graft Outflow Stenosis (BRAVO II)Novel paradigms for dialysis vascular access: Introduction.Novel therapies for hemodialysis vascular access dysfunction: myth or reality?Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.Therapeutic strategies to combat neointimal hyperplasia in vascular grafts.Back to the future: how biology and technology could change the role of PTFE grafts in vascular access management.Future directions for vascular access for hemodialysis.Surgical Options in the Problematic Arteriovenous Haemodialysis Access.Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures.Effectiveness of beraprost sodium in maintaining vascular access patency in patients on hemodialysis.

P2860

Q24186417-8EFFF163-88FD-4FAD-8C28-52BE6E251892 Q24197614-46F87C3F-0C22-4C1C-948A-8CF0DD372595 Q24200752-A6B3E014-67E6-4D6F-A732-831D247D4E19 Q26780134-8D83C5CA-8287-4B11-9942-2EC24389D55A Q28397805-32F6F368-349C-4DBA-871F-45A333B78C4C Q30412623-1A532228-E89F-4C0B-A6CB-3A3BADE966A0 Q33414182-02CD0AB3-DC5E-46DF-9166-F4CDFBA9C201 Q33888388-F3299E84-36AA-42B6-A474-C7635DE79837 Q34034751-27AA33E0-EB31-4229-9088-EC40CDB94195 Q34075472-04D4879F-3204-469B-896A-11BF7BE0251C Q34726912-A54078AF-C142-47C6-8AAB-32B6308DB835 Q34787783-B3A138B1-8644-4507-8078-BCB3A50647F8 Q35027428-69F988C3-0149-4704-9DA7-AEC6F75D9664 Q35070809-5F279275-36EB-4719-A6A4-DB434A53E5BF Q35133067-39F1F6FB-881C-4B7C-95F0-742D75C99F61 Q35627010-375A8069-6100-468F-B873-9B11FE2013B1 Q35770697-C6E2EB09-F90F-467B-818A-61AA3D2494D6 Q35894772-2A88D925-5E8C-4C0E-81B5-2A2B67EBDC66 Q36044303-4FAD7FC3-1011-432A-B517-381C61BFE11E Q36188933-0779BAEA-8873-4B60-B061-4FFC8FFC5382 Q36265484-B42E5F92-4112-465B-861F-930F7E60B20A Q36349395-E1D13C07-CF85-4A90-A9F9-010C7B189A4D Q36503391-410BCDCC-C811-4E4C-A2F1-2994B4EAAC21 Q36740476-3C16398A-68AF-466A-8AF4-B8E21A6A500A Q36910895-1FE58650-A449-42DA-8FA2-7CEA20FEFF54 Q37022867-E58D10E1-6DC0-4353-A4DE-B78D73D7D6C0 Q37026285-E83D57E6-22EB-45AD-A54E-C26DD1F08C0D Q37185094-33E0A806-E113-46C4-82BF-C534D507BABB Q37195358-E4D48B4E-AD12-4D49-8CB4-B102D4B2FC13 Q37202766-B4A5972C-6F63-4E71-83EE-36C806355A2F Q37334204-6CE0AC4D-FE64-4BB8-BA50-CA28FE416ED5 Q37359068-9214561B-2792-47D9-B4E6-04E13E0BFFB1 Q37359091-D4AA7CD9-E253-4DC6-A6C4-7DBAF81810FD Q37393223-4899543F-8C21-49C9-9193-7F0834BEA775 Q38014981-6311BDE0-883A-42BD-A5E1-2B0CD77DAA2B Q38036346-90E6352B-52A5-4A55-832A-E2008CD83261 Q38284266-4122AF57-45DE-4F2D-AC9D-040C5FA28657 Q38543669-D8A14FF8-F757-4A9E-8478-EE3C5187DB49 Q38817264-F96D9DCF-0F35-40BA-8A67-6C56097DC469 Q38837231-62CD422E-7472-4635-B584-6C881710FBBE

P2860

Effect of dipyridamole plus aspirin on hemodialysis graft patency

http://www.wikidata.org/entity/Q34607985

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@ast

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@en

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@nl

type

label

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@ast

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@en

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@nl

prefLabel

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@ast

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@en

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@nl

P1433

Q34607985-9C0EC925-C46C-41FA-A2D7-4412855863FF

P1476

Q34607985-8194C770-5199-49DF-BB8C-CE1822065606

P2093

Q34607985-08E847EF-3589-499A-9FD6-43324B322F21

Q34607985-0BB4D0CA-BA3A-420C-9298-F8C907764C76

Q34607985-153B987A-1FFB-48E1-B62F-DC8D20D28F7D

Q34607985-1B41EFD3-7F51-4314-9460-0FC82181EEC7

Q34607985-1E7A2247-740D-40F0-825E-967A981DF7DF

Q34607985-2F62C050-138D-42BF-86B4-FFC50C6D1C23

Q34607985-3D2B277E-4253-42AB-986A-C59705A377A2

Q34607985-43F8FBA3-AF0C-483A-9A23-FB5875D789E4

Q34607985-5AA0E220-F8DC-4D67-8043-3744A1C5A66D

Q34607985-61480F2C-080A-4783-9C88-B0F887E32FF5

P2860

Q34607985-013542EF-BFEC-47A2-B89E-86981E668B95

Q34607985-1A745F0F-2645-4691-A6C7-5461DF90CAF1

Q34607985-2246BE39-E0F1-40A2-910C-8B873D8117DC

Q34607985-28BDF203-4D7A-41BF-9729-DD081546BC10

Q34607985-3B051CD7-A10C-435D-A3EE-8DE5FFD836EC

Q34607985-42293286-1DEB-4FF6-BA43-80F3DF623B3D

Q34607985-425206E6-1062-4893-B3AF-990133B14DA5

Q34607985-5BE15B0C-D27B-405D-A89B-2D7B9A6B6E99

Q34607985-664F4C22-0D91-4EA7-8184-07DF4D6F236C

Q34607985-864484BE-7750-4FE0-A028-70EBA6B31D79

P304

Q34607985-28C7A931-AA5D-4768-9704-8C38322F3DC9

P31

Q34607985-64285728-610C-479A-866C-AAD5121A0EF4

P356

Q34607985-6A274B36-3CB6-4041-B5C5-B9A7A723D2E5

P407

Q34607985-ABFD3AF9-C992-44C4-8498-6FA19C34DD16

P433

Q34607985-996EF086-1D06-4B0F-A2AB-3E1569414D1E

P478

Q34607985-763F22ED-F413-414C-A15C-E862FC5C920D

P577

Q34607985-420E2680-7A59-4CE1-B558-067F8E652FE8

P698

Q34607985-9883A727-F101-4125-9BEC-39C16777DAFD

P921

Q34607985-526B4683-57DA-4492-B301-28D2B9B360C9

P932

Q34607985-D46DB505-AEB6-4171-BB56-EFD2E148ED66

P356

P1433

The New England Journal of Medicine

P1476

Effect of dipyridamole plus aspirin on hemodialysis graft patency

@en

P2093

Andrew Z Fenves

http://www.w3.org/2001/XMLSchema#string

Arthur Greenberg

http://www.w3.org/2001/XMLSchema#string

Asif Rahman

http://www.w3.org/2001/XMLSchema#string

Bo Hu

http://www.w3.org/2001/XMLSchema#string

Bradley S Dixon

http://www.w3.org/2001/XMLSchema#string

Catherine M Meyers

http://www.w3.org/2001/XMLSchema#string

DAC Study Group

http://www.w3.org/2001/XMLSchema#string

Gerald J Beck

http://www.w3.org/2001/XMLSchema#string

Gregory L Braden

http://www.w3.org/2001/XMLSchema#string

Harold I Feldman

http://www.w3.org/2001/XMLSchema#string

P2860

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial

Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis

Vascular access outcomes and medication use: a USRDS study

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.

Effect of dialysis dose and membrane flux in maintenance hemodialysis.

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.

Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.

P304

2191-2201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0805840

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19458364

http://www.w3.org/2001/XMLSchema#string

P921

P932

3929400

http://www.w3.org/2001/XMLSchema#string